Clinical implications of germline mutations in breast cancer: TP53
ConclusionsIdentifying aTP53 mutation in a gene panel test is a challenging result for the patient and clinician due to the high risk of second primaries and the lack of consensus about surveillance.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Breast Lumpectomy | Cancer | Cancer & Oncology | Childhood Cancer | Clinical Trials | Genetics | HER2 | Hormones | Lumpectomy | Mastectomy | Sarcomas | Soft Tissue Sarcoma | Women